MS

Morgan Stanley
D

MS

Arincen79/100B

Morgan Stanley stock buybacks 1989–2026

Morgan Stanley spent 1.56B USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, up 36.5% on the same quarter a year before. Morgan Stanley spent 1.07B USD buying back its shares over the last twelve months, down 79.3% on the twelve months before. In fiscal year 2025 it spent 5.84B USD, up 39.0% on the year before.

Last updated 8 Nov 2026 · Next report 14 Jan 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20261.07B-79.27%6.98B—
FY202531 Dec 20255.84B+38.96%6.59B46.10B
FY202431 Dec 20244.20B-32.03%6.14B-2.10B
FY202331 Dec 20236.18B-43.17%5.76B-36.95B
FY202231 Dec 202210.87B-9.97%5.40B-9.48B
FY202131 Dec 202112.08B+538.89%4.17B31.66B
FY202031 Dec 20201.89B-68.26%2.74B-26.68B
FY201931 Dec 20195.95B+6.97%2.63B38.95B
FY201831 Dec 20185.57B+29.68%2.38B5.44B
FY201731 Dec 20174.29B+9.13%2.09B-6.13B
FY201631 Dec 20163.93B+41.83%1.75B1.17B
FY201531 Dec 20152.77B+90.19%1.46B2.30B
FY201431 Dec 20141.46B+111.00%904.00M139.00M
FY201331 Dec 2013691.00M+204.41%475.00M33.69B
FY201231 Dec 2012227.00M-28.39%469.00M23.45B
FY201131 Dec 2011317.00M0.00%834.00M14.08B
FY201031 Dec 2010317.00M-97.12%1.16B39.41B
FY200931 Dec 200911.00B+501.75%1.73B-48.83B
FY200831 Dec 20081.83B-57.06%1.23B72.02B
FY200730 Nov 20074.26B+26.10%1.22B-23.56B
FY200630 Nov 20063.38B-8.58%1.17B-60.80B
FY200530 Nov 20053.69B+226.24%1.18B-31.89B
FY200430 Nov 20041.13B+223.43%1.10B-25.08B
FY200330 Nov 2003350.00M-64.65%994.00M1.75B
FY200230 Nov 2002990.00M—1.00B-6.18B
FY200130 Nov 20010.00—1.04B-26.09B
FY200030 Nov 20000.00—924.00M-3.22B
FY199930 Nov 19990.00—575.00M-29.93B
FY199830 Nov 19980.00—519.00M15.37B
FY199730 Nov 19970.00—416.00M-889.00M
FY199631 Dec 19960.00—134.00M2.21B
FY199531 Dec 19950.00—102.30M1.48B
FY199431 Dec 19940.00—81.10M2.89B
FY199331 Dec 19930.00—690.30M1.35B
FY199231 Jan 19930.00—102.90M4.73B
FY199131 Dec 19910.00—85.50M-2.97B
FY199031 Dec 19900.00—69.50M-4.84B
FY198931 Dec 19890.00—55.00M-8.53B

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Morgan Stanley's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.